$UBSI

United Bankshares: An Underrated Dividend Stock with a 52-Year Growth Streak

United Bankshares (NASDAQ:UBSI) increased its annual dividend to $1.52 per share, extending its 52-year growth streak. At $47.81, the stock offers a 3.2% yield. Q2 2026 EPS was $0.95, with a 40% payout ratio. The company reported record earnings of $131.4M in Q2 2026, up from $124.2M in Q1, and strong asset quality.

Original reporting
Published Aug 25, 2026, 2:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 25, 2026, 3:19 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
United Bankshares: An Underrated Dividend Stock with a 52-Year Growth Streak — source image
Decision brief

The 30-second read

$UBSIBullishLow
01

Why it matters

The earnings beat and dividend increase reinforce the bank's income‑focused narrative, likely attracting dividend investors.

02

Market read

Provides fresh earnings and dividend data for a dividend‑seeking audience.

03

What to watch

Potential credit loss exposure not fully addressed in the brief.

Relevance 6/10Novelty 6/10Timing: post‑market Q2 2026 release

Background

United Bankshares is a NASDAQ‑listed regional bank known for a long dividend‑growth record.

Company-level read

Ticker impact

$UBSIBullishMedium confidence
Context

Q2 2026 earnings disclosed EPS of $0.95 and a 2.7% dividend increase to $1.52, extending the dividend streak to 52 years.

Expected impact

Modest upside as dividend‑focused investors may add to the stock.

Evidence & confidence

First‑report earnings and dividend increase provide fresh data; scale is modest for a regional bank.

Market effects

Highlights dividend reliability in regional banking, may influence peer valuation.

Limited to U.S. regional bank space.

Low

Counterpoint

Dividend growth may be unsustainable if interest rates rise sharply.

Key entities

  • United Bankshares, Inc.

    Regional bank reporting Q2 2026 results.

Related articles

$UBSIMed

UNITED BANKSHARES INC/WV (UBSI): Results of Operations and Financial Condition

UNITED BANKSHARES INC/WV (UBSI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d139267dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 News Release For Immediate Release Contact: W. Mark Tatterson July 23, 2026 Chief Financial Officer (800) 445-1347 ext. 8716 United Bankshares, Inc. Announces Record Earnings for the Second Quarter of 2026 WASHINGTON, D.C.

$UALMed

United CEO sends an alert on what's coming for airfares in 2027

United Airlines CEO Scott Kirby expects airfares to return to pre-pandemic levels by 2027, with gradual increases driven by strong demand and improved service. The airline's Q2 results showed record on-time performance and high customer satisfaction. United's full-year 2026 adjusted EPS guidance remains $9.00-$11.00. Investors may see potential if demand remains robust.

$BJHighAI 8/10

BJ’s Wholesale Club (BJ) Notches Record Members Amid A Split Economy

BJ’s Wholesale Club (BJ) reported Q2 net sales of $6.1B (+15.9% YoY) and adjusted EPS of $1.36 (+19.3% YoY). Memberships hit a record 8.5M, with higher-tier memberships at 43%. Digital sales grew 30%, and fuel sales outperformed industry trends. However, merchandise gross margin fell 20 bps, and membership fee growth is expected to moderate.

$AIZMedAI 8/10

Do Wall Street Analysts Like Assurant Stock?

Assurant (AIZ) stock has risen 34.7% over the past year, outperforming the S&P 500. Q2 2026 revenue was $3.5B, up 6.9% YoY, with adjusted EPS of $6.41. Analysts expect 11.5% EPS growth for the year. Nine analysts rate it 'Strong Buy,' with a mean price target of $321.43, implying 11.4% upside.

$KNMed

Knowles Targets 30% Margins as Specialty Components Drive Growth

Knowles Corporation (KN) aims for 30% EBITDA margins within 36 months, driven by growth in specialty components. The company reported 11% EBITDA growth from 2017-2025, with recent organic growth exceeding 10%. Precision Devices is expected to grow over 15% this year, while hearing-health margins remain above 50% gross and 40% EBITDA. Knowles plans to reduce debt and continue selective acquisitions.